{ "drug": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "asOf": "2026-08-25", "status": "in-shortage", "since": "10/12/2022", "dayN": 1413, "cat": "Psychiatry", "companies": [ "Alvogen", "Elite Laboratories, Inc.", "Oryza Pharmaceuticals Inc.", "Granules Pharmaceuticals Inc.", "Sunrise Pharmaceutical, Inc.", "Teva Pharmaceuticals USA, Inc.", "Lannett Company, Inc.", "SpecGx LLC", "Epic Pharma, LLC", "Sandoz Inc.", "Aurobindo Pharma USA" ], "reasons": [ "Shortage of an active ingredient", "Demand increase for the drug", "Other" ], "records": [ { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "47781-179-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com", "availability": "Available", "openfda": { "application_number": [ "ANDA207388" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 20 MG,CLL" ], "manufacturer_name": [ "Alvogen Inc." ], "product_ndc": [ "47781-179", "47781-174", "47781-175", "47781-176", "47781-177", "47781-178", "47781-180" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "0374f0f7-9297-810c-38b3-623a72709a7d" ], "spl_set_id": [ "c907301d-e24d-9609-5529-fed14f94549f" ], "package_ndc": [ "47781-174-30", "47781-174-05", "47781-174-01", "47781-175-30", "47781-175-05", "47781-175-01", "47781-176-30", "47781-176-05", "47781-176-01", "47781-177-30", "47781-177-05", "47781-177-01", "47781-178-30", "47781-178-05", "47781-178-01", "47781-179-30", "47781-179-05", "47781-179-01", "47781-180-30", "47781-180-05", "47781-180-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01)", "company_name": "Alvogen", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-504-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-504", "64850-500", "64850-501", "64850-502", "64850-503", "64850-505", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "72516-016-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027", "openfda": { "application_number": [ "ANDA210293" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Oryza Pharmaceuticals Inc." ], "product_ndc": [ "72516-016", "72516-015", "72516-014", "72516-013", "72516-012", "72516-011" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "5734011d-5044-b490-e063-6394a90a3174" ], "spl_set_id": [ "acd27181-a3f3-4c38-85d8-029a4a82e7c2" ], "package_ndc": [ "72516-016-01", "72516-015-01", "72516-014-01", "72516-013-01", "72516-012-01", "72516-011-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-117-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-117", "70010-111", "70010-112", "70010-113", "70010-114", "70010-115", "70010-116" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-500-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-500", "64850-501", "64850-502", "64850-503", "64850-504", "64850-505", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-191-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-191", "11534-190", "11534-192", "11534-193", "11534-194", "11534-195", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0777-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0777", "0555-0971", "0555-0775", "0555-0972", "0555-0776", "0555-0973", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0527-0763-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-834-0530", "availability": "Available", "openfda": { "application_number": [ "ANDA215565" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Lannett Company, LLC" ], "product_ndc": [ "0527-0763", "0527-0760", "0527-0761", "0527-0762", "0527-0764", "0527-0765", "0527-0766" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "391d7c4a-47df-41ce-b1ba-3c4758adf87f" ], "spl_set_id": [ "f92497b5-baea-4760-b615-45a0b6184402" ], "package_ndc": [ "0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)", "company_name": "Lannett Company, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-105-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-105", "57844-117", "57844-110", "57844-112", "57844-115", "57844-120", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8893-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Available", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8893", "0406-8891", "0406-8884", "0406-8892", "0406-8885", "0406-8894" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)", "company_name": "SpecGx LLC", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8884-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Available", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8884", "0406-8891", "0406-8892", "0406-8885", "0406-8893", "0406-8894" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)", "company_name": "SpecGx LLC", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "72516-014-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027", "openfda": { "application_number": [ "ANDA210293" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Oryza Pharmaceuticals Inc." ], "product_ndc": [ "72516-014", "72516-016", "72516-015", "72516-013", "72516-012", "72516-011" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "5734011d-5044-b490-e063-6394a90a3174" ], "spl_set_id": [ "acd27181-a3f3-4c38-85d8-029a4a82e7c2" ], "package_ndc": [ "72516-016-01", "72516-015-01", "72516-014-01", "72516-013-01", "72516-012-01", "72516-011-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0776-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0776", "0555-0971", "0555-0775", "0555-0972", "0555-0777", "0555-0973", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0973-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0973", "0555-0971", "0555-0775", "0555-0972", "0555-0776", "0555-0777", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "42806-343-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(718) 276-8600 ext. 3", "availability": "Available", "openfda": { "application_number": [ "ANDA040444" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Epic Pharma, LLC" ], "product_ndc": [ "42806-343", "42806-339", "42806-341", "42806-344", "42806-345" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961" ], "spl_id": [ "f11301e2-3b5d-468d-b44c-45839e7e5dfb" ], "spl_set_id": [ "1757e132-061d-4773-89ed-fdc77f69008f" ], "package_ndc": [ "42806-339-01", "42806-341-01", "42806-343-01", "42806-344-01", "42806-345-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)", "company_name": "Epic Pharma, LLC", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0185-2098-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available", "openfda": { "application_number": [ "ANDA040439" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Sandoz Inc" ], "product_ndc": [ "0185-2098", "0185-0831", "0185-0842", "0185-0853", "0185-0864", "0185-2099" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577961" ], "spl_id": [ "9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd" ], "spl_set_id": [ "288dafc4-fe6e-4891-832f-511022c87445" ], "package_ndc": [ "0185-0831-01", "0185-0842-01", "0185-0853-01", "0185-0864-01", "0185-2099-01", "0185-2098-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)", "company_name": "Sandoz Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "08/15/2023", "package_ndc": "64850-506-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-506", "64850-500", "64850-501", "64850-502", "64850-503", "64850-504", "64850-505" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-196-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-196", "11534-190", "11534-191", "11534-192", "11534-193", "11534-194", "11534-195" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8894-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8894", "0406-8891", "0406-8884", "0406-8892", "0406-8885", "0406-8893" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/05/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)", "company_name": "SpecGx LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-193-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-193", "11534-190", "11534-191", "11534-192", "11534-194", "11534-195", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-117-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-117", "57844-105", "57844-110", "57844-112", "57844-115", "57844-120", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-073-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 or CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-073", "13107-068", "13107-069", "13107-070", "13107-071", "13107-072", "13107-074" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "42806-344-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(718) 276-8600 ext. 3", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD", "openfda": { "application_number": [ "ANDA040444" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Epic Pharma, LLC" ], "product_ndc": [ "42806-344", "42806-339", "42806-341", "42806-343", "42806-345" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961" ], "spl_id": [ "f11301e2-3b5d-468d-b44c-45839e7e5dfb" ], "spl_set_id": [ "1757e132-061d-4773-89ed-fdc77f69008f" ], "package_ndc": [ "42806-339-01", "42806-341-01", "42806-343-01", "42806-344-01", "42806-345-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)", "company_name": "Epic Pharma, LLC", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "42806-339-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(718) 276-8600 ext. 3", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD", "openfda": { "application_number": [ "ANDA040444" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Epic Pharma, LLC" ], "product_ndc": [ "42806-339", "42806-341", "42806-343", "42806-344", "42806-345" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961" ], "spl_id": [ "f11301e2-3b5d-468d-b44c-45839e7e5dfb" ], "spl_set_id": [ "1757e132-061d-4773-89ed-fdc77f69008f" ], "package_ndc": [ "42806-339-01", "42806-341-01", "42806-343-01", "42806-344-01", "42806-345-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)", "company_name": "Epic Pharma, LLC", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0185-0853-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available", "openfda": { "application_number": [ "ANDA040439" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Sandoz Inc" ], "product_ndc": [ "0185-0853", "0185-0831", "0185-0842", "0185-0864", "0185-2099", "0185-2098" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577961" ], "spl_id": [ "9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd" ], "spl_set_id": [ "288dafc4-fe6e-4891-832f-511022c87445" ], "package_ndc": [ "0185-0831-01", "0185-0842-01", "0185-0853-01", "0185-0864-01", "0185-2099-01", "0185-2098-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)", "company_name": "Sandoz Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-110-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-110", "57844-105", "57844-117", "57844-112", "57844-115", "57844-120", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-111-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-111", "70010-112", "70010-113", "70010-114", "70010-115", "70010-116", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-192-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-192", "11534-190", "11534-191", "11534-193", "11534-194", "11534-195", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-130-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-130", "57844-105", "57844-117", "57844-110", "57844-112", "57844-115", "57844-120" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)", "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0527-1505-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "company_name": "Lannett Company, Inc.", "contact_info": "844-834-0530", "availability": "Available", "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "status": "Current", "dosage_form": "Tablet" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0775-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0775", "0555-0971", "0555-0972", "0555-0776", "0555-0777", "0555-0973", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "47781-176-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com", "availability": "Available", "openfda": { "application_number": [ "ANDA207388" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 10 MG,CLL" ], "manufacturer_name": [ "Alvogen Inc." ], "product_ndc": [ "47781-176", "47781-174", "47781-175", "47781-177", "47781-178", "47781-179", "47781-180" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "0374f0f7-9297-810c-38b3-623a72709a7d" ], "spl_set_id": [ "c907301d-e24d-9609-5529-fed14f94549f" ], "package_ndc": [ "47781-174-30", "47781-174-05", "47781-174-01", "47781-175-30", "47781-175-05", "47781-175-01", "47781-176-30", "47781-176-05", "47781-176-01", "47781-177-30", "47781-177-05", "47781-177-01", "47781-178-30", "47781-178-05", "47781-178-01", "47781-179-30", "47781-179-05", "47781-179-01", "47781-180-30", "47781-180-05", "47781-180-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01)", "company_name": "Alvogen", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "57844-112-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-112", "57844-105", "57844-117", "57844-110", "57844-115", "57844-120", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-112-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-112", "70010-111", "70010-113", "70010-114", "70010-115", "70010-116", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-072-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 OR CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-072", "13107-068", "13107-069", "13107-070", "13107-071", "13107-073", "13107-074" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-120-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-120", "57844-105", "57844-117", "57844-110", "57844-112", "57844-115", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-114-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-114", "70010-111", "70010-112", "70010-113", "70010-115", "70010-116", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "42806-341-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(718) 276-8600 ext. 3", "availability": "Available", "openfda": { "application_number": [ "ANDA040444" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Epic Pharma, LLC" ], "product_ndc": [ "42806-341", "42806-339", "42806-343", "42806-344", "42806-345" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961" ], "spl_id": [ "f11301e2-3b5d-468d-b44c-45839e7e5dfb" ], "spl_set_id": [ "1757e132-061d-4773-89ed-fdc77f69008f" ], "package_ndc": [ "42806-339-01", "42806-341-01", "42806-343-01", "42806-344-01", "42806-345-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)", "company_name": "Epic Pharma, LLC", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "72516-011-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027", "openfda": { "application_number": [ "ANDA210293" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Oryza Pharmaceuticals Inc." ], "product_ndc": [ "72516-011", "72516-016", "72516-015", "72516-014", "72516-013", "72516-012" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "5734011d-5044-b490-e063-6394a90a3174" ], "spl_set_id": [ "acd27181-a3f3-4c38-85d8-029a4a82e7c2" ], "package_ndc": [ "72516-016-01", "72516-015-01", "72516-014-01", "72516-013-01", "72516-012-01", "72516-011-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-195-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-195", "11534-190", "11534-191", "11534-192", "11534-193", "11534-194", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-505-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-505", "64850-500", "64850-501", "64850-502", "64850-503", "64850-504", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-194-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-194", "11534-190", "11534-191", "11534-192", "11534-193", "11534-195", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0974-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0974", "0555-0971", "0555-0775", "0555-0972", "0555-0776", "0555-0777", "0555-0973" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0972-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0972", "0555-0971", "0555-0775", "0555-0776", "0555-0777", "0555-0973", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "42806-345-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(718) 276-8600 ext. 3", "availability": "Available", "openfda": { "application_number": [ "ANDA040444" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Epic Pharma, LLC" ], "product_ndc": [ "42806-345", "42806-339", "42806-341", "42806-343", "42806-344" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961" ], "spl_id": [ "f11301e2-3b5d-468d-b44c-45839e7e5dfb" ], "spl_set_id": [ "1757e132-061d-4773-89ed-fdc77f69008f" ], "package_ndc": [ "42806-339-01", "42806-341-01", "42806-343-01", "42806-344-01", "42806-345-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)", "company_name": "Epic Pharma, LLC", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0527-0764-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-834-0530", "availability": "Available", "openfda": { "application_number": [ "ANDA215565" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Lannett Company, LLC" ], "product_ndc": [ "0527-0764", "0527-0760", "0527-0761", "0527-0762", "0527-0763", "0527-0765", "0527-0766" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "391d7c4a-47df-41ce-b1ba-3c4758adf87f" ], "spl_set_id": [ "f92497b5-baea-4760-b615-45a0b6184402" ], "package_ndc": [ "0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)", "company_name": "Lannett Company, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0185-2099-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available", "openfda": { "application_number": [ "ANDA040439" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Sandoz Inc" ], "product_ndc": [ "0185-2099", "0185-0831", "0185-0842", "0185-0853", "0185-0864", "0185-2098" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577961" ], "spl_id": [ "9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd" ], "spl_set_id": [ "288dafc4-fe6e-4891-832f-511022c87445" ], "package_ndc": [ "0185-0831-01", "0185-0842-01", "0185-0853-01", "0185-0864-01", "0185-2099-01", "0185-2098-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)", "company_name": "Sandoz Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "47781-174-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com", "availability": "Available", "openfda": { "application_number": [ "ANDA207388" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 5 MG,CLL" ], "manufacturer_name": [ "Alvogen Inc." ], "product_ndc": [ "47781-174", "47781-175", "47781-176", "47781-177", "47781-178", "47781-179", "47781-180" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "0374f0f7-9297-810c-38b3-623a72709a7d" ], "spl_set_id": [ "c907301d-e24d-9609-5529-fed14f94549f" ], "package_ndc": [ "47781-174-30", "47781-174-05", "47781-174-01", "47781-175-30", "47781-175-05", "47781-175-01", "47781-176-30", "47781-176-05", "47781-176-01", "47781-177-30", "47781-177-05", "47781-177-01", "47781-178-30", "47781-178-05", "47781-178-01", "47781-179-30", "47781-179-05", "47781-179-01", "47781-180-30", "47781-180-05", "47781-180-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01)", "company_name": "Alvogen", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-501-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-501", "64850-500", "64850-502", "64850-503", "64850-504", "64850-505", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0527-0760-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-834-0530", "availability": "Available", "openfda": { "application_number": [ "ANDA215565" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Lannett Company, LLC" ], "product_ndc": [ "0527-0760", "0527-0761", "0527-0762", "0527-0763", "0527-0764", "0527-0765", "0527-0766" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "391d7c4a-47df-41ce-b1ba-3c4758adf87f" ], "spl_set_id": [ "f92497b5-baea-4760-b615-45a0b6184402" ], "package_ndc": [ "0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)", "company_name": "Lannett Company, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8885-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Available", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8885", "0406-8891", "0406-8884", "0406-8892", "0406-8893", "0406-8894" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/20/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)", "company_name": "SpecGx LLC", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "72516-013-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027", "openfda": { "application_number": [ "ANDA210293" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Oryza Pharmaceuticals Inc." ], "product_ndc": [ "72516-013", "72516-016", "72516-015", "72516-014", "72516-012", "72516-011" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "5734011d-5044-b490-e063-6394a90a3174" ], "spl_set_id": [ "acd27181-a3f3-4c38-85d8-029a4a82e7c2" ], "package_ndc": [ "72516-016-01", "72516-015-01", "72516-014-01", "72516-013-01", "72516-012-01", "72516-011-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "72516-012-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027", "openfda": { "application_number": [ "ANDA210293" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Oryza Pharmaceuticals Inc." ], "product_ndc": [ "72516-012", "72516-016", "72516-015", "72516-014", "72516-013", "72516-011" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "5734011d-5044-b490-e063-6394a90a3174" ], "spl_set_id": [ "acd27181-a3f3-4c38-85d8-029a4a82e7c2" ], "package_ndc": [ "72516-016-01", "72516-015-01", "72516-014-01", "72516-013-01", "72516-012-01", "72516-011-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-116-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-116", "70010-111", "70010-112", "70010-113", "70010-114", "70010-115", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0555-0971-02", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "0555-0971", "0555-0775", "0555-0972", "0555-0776", "0555-0777", "0555-0973", "0555-0974" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "88468f3d-7d03-4cee-aabf-3abc8c9b5e38" ], "spl_set_id": [ "cffbbb15-d776-41ae-a8a6-687f2c07bfa4" ], "package_ndc": [ "0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-074-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 OR CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-074", "13107-068", "13107-069", "13107-070", "13107-071", "13107-072", "13107-073" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0185-0842-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available", "openfda": { "application_number": [ "ANDA040439" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Sandoz Inc" ], "product_ndc": [ "0185-0842", "0185-0831", "0185-0853", "0185-0864", "0185-2099", "0185-2098" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577961" ], "spl_id": [ "9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd" ], "spl_set_id": [ "288dafc4-fe6e-4891-832f-511022c87445" ], "package_ndc": [ "0185-0831-01", "0185-0842-01", "0185-0853-01", "0185-0864-01", "0185-2099-01", "0185-2098-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)", "company_name": "Sandoz Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "47781-180-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com", "availability": "Available", "openfda": { "application_number": [ "ANDA207388" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 30 MG,CLL" ], "manufacturer_name": [ "Alvogen Inc." ], "product_ndc": [ "47781-180", "47781-174", "47781-175", "47781-176", "47781-177", "47781-178", "47781-179" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "0374f0f7-9297-810c-38b3-623a72709a7d" ], "spl_set_id": [ "c907301d-e24d-9609-5529-fed14f94549f" ], "package_ndc": [ "47781-174-30", "47781-174-05", "47781-174-01", "47781-175-30", "47781-175-05", "47781-175-01", "47781-176-30", "47781-176-05", "47781-176-01", "47781-177-30", "47781-177-05", "47781-177-01", "47781-178-30", "47781-178-05", "47781-178-01", "47781-179-30", "47781-179-05", "47781-179-01", "47781-180-30", "47781-180-05", "47781-180-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01)", "company_name": "Alvogen", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "57844-115-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-545-8800", "availability": "Available", "openfda": { "application_number": [ "ANDA040422" ], "brand_name": [ "ADDERALL" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Teva Pharmaceuticals USA, Inc." ], "product_ndc": [ "57844-115", "57844-105", "57844-117", "57844-110", "57844-112", "57844-120", "57844-130" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147" ], "spl_id": [ "79af1dc6-c7cf-41b1-a750-e9b47c2187ff" ], "spl_set_id": [ "f22635fe-821d-4cde-aa12-419f8b53db81" ], "package_ndc": [ "57844-105-01", "57844-117-01", "57844-110-01", "57844-112-01", "57844-115-01", "57844-120-01", "57844-130-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-113-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-113", "70010-111", "70010-112", "70010-114", "70010-115", "70010-116", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-503-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-503", "64850-500", "64850-501", "64850-502", "64850-504", "64850-505", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "64850-502-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "888-852-6657", "availability": "Available", "openfda": { "application_number": [ "ANDA211352" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Elite Laboratories, Inc." ], "product_ndc": [ "64850-502", "64850-500", "64850-501", "64850-503", "64850-504", "64850-505", "64850-506" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "a41cf8e5-cb1b-488c-96b3-3bef8283d6c4" ], "spl_set_id": [ "e677690f-790f-4626-ad78-097cdb6ea540" ], "package_ndc": [ "64850-500-01", "64850-500-05", "64850-500-30", "64850-501-01", "64850-501-05", "64850-501-30", "64850-502-01", "64850-502-05", "64850-502-30", "64850-503-01", "64850-503-05", "64850-503-30", "64850-504-01", "64850-504-05", "64850-504-30", "64850-505-01", "64850-505-05", "64850-505-30", "64850-506-01", "64850-506-05", "64850-506-30" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)", "company_name": "Elite Laboratories, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "70010-115-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "877-770-3183", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026", "openfda": { "application_number": [ "ANDA215771" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Granules Pharmaceuticals Inc." ], "product_ndc": [ "70010-115", "70010-111", "70010-112", "70010-113", "70010-114", "70010-116", "70010-117" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "56c7c921-e560-c5ad-e063-6294a90a4c81" ], "spl_set_id": [ "b0b4eccc-34c7-483d-966f-82d588358e1b" ], "package_ndc": [ "70010-111-01", "70010-111-03", "70010-112-01", "70010-112-03", "70010-113-01", "70010-113-03", "70010-114-01", "70010-114-03", "70010-115-01", "70010-115-03", "70010-116-01", "70010-116-03", "70010-117-01", "70010-117-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)", "company_name": "Granules Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0527-0766-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-834-0530", "availability": "Available", "openfda": { "application_number": [ "ANDA215565" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Lannett Company, LLC" ], "product_ndc": [ "0527-0766", "0527-0760", "0527-0761", "0527-0762", "0527-0763", "0527-0764", "0527-0765" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "391d7c4a-47df-41ce-b1ba-3c4758adf87f" ], "spl_set_id": [ "f92497b5-baea-4760-b615-45a0b6184402" ], "package_ndc": [ "0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)", "company_name": "Lannett Company, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-069-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 or CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-069", "13107-068", "13107-070", "13107-071", "13107-072", "13107-073", "13107-074" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "47781-178-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-842-8672 and email: CustomerService-US@alvogen.com", "availability": "Available", "openfda": { "application_number": [ "ANDA207388" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 15 MG,CLL" ], "manufacturer_name": [ "Alvogen Inc." ], "product_ndc": [ "47781-178", "47781-174", "47781-175", "47781-176", "47781-177", "47781-179", "47781-180" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "0374f0f7-9297-810c-38b3-623a72709a7d" ], "spl_set_id": [ "c907301d-e24d-9609-5529-fed14f94549f" ], "package_ndc": [ "47781-174-30", "47781-174-05", "47781-174-01", "47781-175-30", "47781-175-05", "47781-175-01", "47781-176-30", "47781-176-05", "47781-176-01", "47781-177-30", "47781-177-05", "47781-177-01", "47781-178-30", "47781-178-05", "47781-178-01", "47781-179-30", "47781-179-05", "47781-179-01", "47781-180-30", "47781-180-05", "47781-180-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01)", "company_name": "Alvogen", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-068-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 or CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-068", "13107-069", "13107-070", "13107-071", "13107-072", "13107-073", "13107-074" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "11534-190-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "732-382-6085 Monday to Friday 9 am to 3:45 pm", "availability": "Available", "openfda": { "application_number": [ "ANDA209799" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SUNRISE PHARMACEUTICAL, INC." ], "product_ndc": [ "11534-190", "11534-191", "11534-192", "11534-193", "11534-194", "11534-195", "11534-196" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "60dcfbf6-d07a-4010-ae77-8a9ae4529828" ], "spl_set_id": [ "ac102599-3a5b-4154-899e-6ff262be7ff7" ], "package_ndc": [ "11534-190-01", "11534-190-03", "11534-191-01", "11534-191-03", "11534-192-01", "11534-192-03", "11534-193-01", "11534-193-03", "11534-194-01", "11534-194-03", "11534-195-01", "11534-195-03", "11534-196-01", "11534-196-03" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/16/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)", "company_name": "Sunrise Pharmaceutical, Inc.", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8892-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8892", "0406-8891", "0406-8884", "0406-8885", "0406-8893", "0406-8894" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/05/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)", "company_name": "SpecGx LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" }, { "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0406-8891-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-325-8888", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD", "openfda": { "application_number": [ "ANDA040440" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "SpecGx LLC" ], "product_ndc": [ "0406-8891", "0406-8884", "0406-8892", "0406-8885", "0406-8893", "0406-8894" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "1009145" ], "spl_id": [ "0d3fb5ba-ff79-4862-bc1d-45b8343e115b" ], "spl_set_id": [ "72ddd1c9-ddbd-4c95-acd9-003189a353a3" ], "package_ndc": [ "0406-8891-01", "0406-8884-01", "0406-8892-01", "0406-8885-01", "0406-8893-01", "0406-8894-01" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/05/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)", "company_name": "SpecGx LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" }, { "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)", "update_type": "Revised", "initial_posting_date": "10/12/2022", "package_ndc": "0527-1502-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "company_name": "Lannett Company, Inc.", "contact_info": "844-834-0530", "availability": "Available", "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "status": "Current", "dosage_form": "Tablet" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "0527-0761-37", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "844-834-0530", "availability": "Available", "openfda": { "application_number": [ "ANDA215565" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Lannett Company, LLC" ], "product_ndc": [ "0527-0761", "0527-0760", "0527-0762", "0527-0763", "0527-0764", "0527-0765", "0527-0766" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "391d7c4a-47df-41ce-b1ba-3c4758adf87f" ], "spl_set_id": [ "f92497b5-baea-4760-b615-45a0b6184402" ], "package_ndc": [ "0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "08/18/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)", "company_name": "Lannett Company, Inc.", "status": "Current" }, { "update_type": "Reverified", "initial_posting_date": "10/12/2022", "package_ndc": "13107-070-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "(866) 850-2876 or CustomerService@AurobindoUSA.com", "availability": "Unavailable", "related_info": "Estimated availability: October 2026", "openfda": { "application_number": [ "ANDA202424" ], "brand_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "generic_name": [ "DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE" ], "manufacturer_name": [ "Aurolife Pharma, LLC" ], "product_ndc": [ "13107-070", "13107-068", "13107-069", "13107-071", "13107-072", "13107-073", "13107-074" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DEXTROAMPHETAMINE SACCHARATE", "AMPHETAMINE ASPARTATE MONOHYDRATE", "DEXTROAMPHETAMINE SULFATE", "AMPHETAMINE SULFATE" ], "rxcui": [ "541363", "541878", "541892", "577957", "577961", "687043", "1009145" ], "spl_id": [ "5962d880-9f18-4a57-8c95-ca0ec1e86f44" ], "spl_set_id": [ "a582d57f-d191-4ca5-b105-585b2d8a0e3e" ], "package_ndc": [ "13107-068-50", "13107-068-01", "13107-068-25", "13107-068-05", "13107-068-99", "13107-069-50", "13107-069-01", "13107-069-25", "13107-069-05", "13107-069-99", "13107-070-50", "13107-070-01", "13107-070-25", "13107-070-05", "13107-070-99", "13107-071-50", "13107-071-01", "13107-071-25", "13107-071-05", "13107-071-99", "13107-072-50", "13107-072-01", "13107-072-25", "13107-072-05", "13107-072-99", "13107-073-50", "13107-073-01", "13107-073-25", "13107-073-05", "13107-073-99", "13107-074-50", "13107-074-01", "13107-074-25", "13107-074-05", "13107-074-99" ], "unii": [ "O1ZPV620O4", "6DPV8NK46S", "JJ768O327N", "G83415V073" ] }, "update_date": "07/21/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)", "company_name": "Aurobindo Pharma USA", "shortage_reason": "Shortage of an active ingredient", "status": "Current" } ] }